A randomized, two-way crossover study to investigate the bioavailability of a single oral dose of 25 mg carbidopa, 100 mg levodopa and 200 mg entacapone compared to a single oral combined dose of both 25 mg carbidopa and 100 mg levodopa and 200 mg entacapone in healthy volunteers under fasting conditions
Latest Information Update: 30 Mar 2007
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Entacapone; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Novartis
- 30 Mar 2007 New trial record.